Properties and benefits investigated
Semax-related neurotrophic signaling and Selank-related anxiety research. Results from the individual compounds do not prove synergistic effects on memory, stress, focus or mood for the mixture.
AVITUS RESEARCHSemax + Selank
Cognitive
Semax + Selank
Two regulatory peptides studied together in neuromodulation models.
- Research category
- Cognitive
- Intended context
- Laboratory research only
For research use only. Not for human or veterinary use. No claims of safety, efficacy or therapeutic benefit.
Evidence and limitations
The cited evidence concerns individual ingredients or related fragments. No controlled study of this exact Avitus blend was identified; synergy and clinical benefits remain unestablished.
References
PMID: 16635254, 18454096
Product specifications.
Contact the Avitus team to confirm available presentations, product specifications and pricing for your research requirements.